Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bjloftus
    Junior Member
    • Sep 2008
    • 2

    #1

    which kit(s) to use for peripheral blood mRNA/miRNA

    Hi,

    Just wondering if there is one kit that would cover mRNA/miRNA from peripheral blood samples and if so what would be a good depth of coverage..or if the sample needs to be split into two seperate pipelines

    Thanks
  • adam.geber
    Member
    • May 2014
    • 40

    #2
    I've done entirely satisfactory RNA extractions with both the Ambion RiboPure blood kit and Qiagen's miRNeasy kits. Just make sure you're doing everything possible to retain your small RNAs! I believe Qiagen has recommendations available on how to increase the binding affinity of RNAs <200nt.

    As to whether your individual samples will be useful for both mRNA and miRNA, you'll certainly have to do your library prep separately because of the size selection step for small RNAs. I've wondered if you can combine these enrichment procedures given that the miRNA and mRNA profiles shouldn't overlap in theory -- perhaps someone else can weigh in on this? I typically split my total RNA samples according to the input mass requirements for polyA or miRNA enrichment, concentrating the miRNA portion as necessary to meet volumetric requirements for e.g. the TruSeq Small RNA kit.

    Comment

    • kerplunk412
      Senior Member
      • Jun 2012
      • 119

      #3
      I agree that you definitely need to split your library preps for miRNA and mRNA. There is no kit that can do both simultaneously, for now. Most small RNA library prep kits work fine from total RNA, so you probably don't need to split your RNA prep as long as you use a method that isolates total RNA including small RNA (as adam.gerber noted this may require a modification to the default Qiagen protocol, just adding more ethanol at the binding step).

      As for read depth, a million per library is usually enough for small RNA, and 10-30 million per library is typical for mRNA, depending on your goals.

      Comment

      • bjloftus
        Junior Member
        • Sep 2008
        • 2

        #4
        Great informative answers and I appreciate the time taken!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...